Respiri grows wheezo market potential through agreement with the Pharmacy Guild of Australia

June 18, 2020by Gillian Alexis
Front view of a female pharmacist with her arms folded standing among shelves with healthcare products

Respiri’s agreement with the Pharmacy Guild of Australia will build awareness and knowledge of its wheeze respiratory evaluation device and technology.

Respiri has already secured telehealth partnerships with Phenix Health and Practice Innovators to grow use and awareness of the technology throughout Australia.

For the full article please visit: https://smallcaps.com.au/respiri-wheezo-market-agreement-pharmacy-guild-of-australia/